The management of unruptured cerebral aneurysms remains one of the most controversial topics in neurosurgery. To this end, we discuss the diagnosis and estimated prevalence of these lesions, as well as review the literature regarding the rate of rupture for cerebral aneurysms and risks of operative intervention. Our interpretation of the literature concludes that aneurysms are present in about 1% of the adult population, varying between <1% in young adults to 4% in the elderly. The yearly risk of SAH for an unruptured intracranial aneurysm is approximately 1% for lesions 7 to 10 mm in diameter. Based on these assumptions, we recommend that 1) with rare exceptions, all symptomatic unruptured aneurysms should be treated; 2) small, incidental aneurysms less than 5mm should be managed conservatively in virtually all cases; 3) aneurysms greater than 5mm in patients less than 60 years of age should be seriously considered for treatment; 4) large, incidental aneurysms greater than 10mm should treated in nearly all patients less than 70 years of age; 5) microsurgical clipping rather than endovascular coiling should be the first choice in low-risk cases. Critical to our guidelines is collaboration by a highly experienced cerebrovascular team of micro-neurosurgeons and endovascular neurosurgeons, working at a tertiary medical center with high case volume, and utilizing a decision-making paradigm designed to offer only low risk treatments. In certain cases where both treatment and natural history carry a high risk, such as with giant aneurysms, non-operative management is typically elected.
INTRODUCTION
The management of unruptured cerebral aneurysms remains one of the most controversial topics in neurosurgery. The International Study of Unruptured Intracranial Aneurysms (ISUIA) investigators have published prospective evaluations regarding the morbidity and mortality (M&M) for the treatment of patients with unruptured intracranial aneurysms (UIAs) (1, 94) . Their findings, however, strongly contrast with the majority of prior estimates (8, 24, 29, 38, 43, 46, 55, 69, 76, 78, 85, 88, 96) . As a result, there have been a number of efforts to determine the true natural history of this condition and define the morbidity and mortality of unruptured cerebral aneurysm surgery as related to patient age, aneurysm size, and aneurysm location. Despite these concerns, no clear consensus has been reached. To this end, we discuss the diagnosis and estimated prevalence of these lesions, as well as review the literature regarding the rate of rupture for cerebral aneurysms and risks of operative intervention. Based on our interpretation of the literature and our extensive experience with managing cerebral aneurysms, we have synthesized a series of management recommendations for patients with unruptured intracranial aneurysms. These recommendations are founded in proper patient selection and the integration of microsurgical and endovascular techniques. Critical to our guidelines is collaboration by a highly experienced cerebrovascular team of microneurosurgeons and endovascular neurosurgeons, working at a tertiary medical center with high case volume, and utilizing a decision-making paradigm designed to offer only low risk treatments. In certain cases where both treatment and natural history carry a high risk, such as with giant aneurysms, non-operative management is typically elected.
DIAGNOSIS OF UNRUPTURED CEREBRAL ANEURYSMS
Unruptured aneurysms may be discovered incidentally or present with neurological symptoms. Raps et al. investigated the presenting symptoms in 111 patients with unruptured aneurysms (66) . The authors found that while 51% were asymptomatic, 17% presented with acute symptomatology and 32% presented with chronic symptomatology.
Acute neurological symptoms included ischemia (37%), headache (37%), seizures (18%), and cranial neuropathies (12%). Chronic neurological symptoms included headache (51%), visual deficits (29%), weakness (11%), and facial pain (9%). As expected, larger aneurysms tended to present with neurological symptoms, as the average aneurysm size for these three groups was 1.1, 2.1, and 2.2cm in maximum diameter, respectively. In addition, symptomatic aneurysms tended to be located along the proximal ICA with diameters never smaller than 3mm.
Initial diagnostic imaging in neurological patients includes computed tomography (CT), magnetic resonance imaging (MRI), CT angiography, and MR angiography. The vast majority of unruptured cerebral aneurysms will be identified through these techniques.
The exceptions include small aneurysms less than 2-3 mm in size that may escape the resolution of CT and MR based imaging. The use of conventional head CT followed by MRA has been shown to have a sensitivity of 76-98% and specificity of 85-100% in detecting unruptured cerebral aneurysm (89, (91) (92) (93) . It is worth noting that while digital subtraction angiography remains the gold-standard for aneurysm delineation, this procedure is invasive, carries small risks, and is being gradually replaced in some situations by improved CTA and MRA technology.
PREVALENCE OF UNRUPTURED ANEURYSMS
The prevalence of unruptured cerebral aneurysms has been estimated to be between 1-6% of the population, depending on the study cited (13, 16, 18, 20, 31, 32, 49, 80) .
Unfortunately, many of these studies lack data regarding the age of these patients, the size and location of aneurysms, and associated pathological variables. As expected, these investigations are biased by the particular patient population included and medical center at which the study is undertaken. The following are studies that have established our currently accepted prevalence rate of unruptured cerebral aneurysms.
Fox and colleagues reviewed 20 autopsy series including a total of more than 160,000 cases (26) . Within these, 1289 unruptured aneurysms were discovered, leading the authors to conclude an occurrence rate of 0.8%. Stehbens et al. published their personal series of 1364 autopsies conducted at one institution and discovered at least one unruptured cerebral aneurysm in 76 patients, resulting in a prevalence rate of 5.6% (80).
Stehbens also published a review of the pathological literature that quoted the prevalence of unruptured cerebral aneurysm to be 2.4%, with a range from 0.2 to 9% (81) . The authors noted that the number of aneurysms discovered might be influenced by both the experience of the pathologists conducting the autopsy as well as the cerebrovascular case volume conducted at specific tertiary referral centers. McCormick's series of 7650 autopsies led to a unruptured cerebral aneurysm prevalence rate estimated at 2% (50) . Of note, when compared with ruptured aneurysms, unruptured aneurysms tended to be smaller (3.9mm vs. 9.9mm) and occurred in older patients (57.9 years of age vs. 46.3).
Romy and colleagues state the prevalence of these lesions to be 1.2%, based on their review of 11,696 autopsies, while Rosenorn et al. estimated this rate to be 0.6% (70, 71) .
Finally, studies from Japan using cerebral angiography have quoted the prevalence of unruptured cerebral aneurysms to be between 2.5-3.0% (88, 97) .
The most comprehensive review regarding the prevalence of unruptured cerebral aneurysms was conducted by Rinkel et al. (69) . Not surprisingly, the authors found the rates to depend on study design, as retrospective reports containing over 43,000 autopsies found lesions in 191 patients (0.4%), while prospective data including nearly 5,500 autopsies discovered aneurysms in 197 cases (3.6%). In addition, retrospective review of 2934 cerebral angiograms found lesions in 108 patients (3.7%), while prospective angiographic data including 3751 patients discovered aneurysms in 225 cases (6.0%).
The authors conclude that the prevalence of unruptured cerebral aneurysms in the general population, without risk factors such as adult polycystic kidney disease or family history of aneurysmal subarachnoid hemorrhage (aSAH), is approximately 2.0%. Our interpretation of the literature asserts that aneurysms are likely present in about 1% of the adult population, varying between <1% in young adults to 4% in the elderly.
NATURAL HISTORY OF UNRUPTURED CEREBRAL ANEURYSMS
When determining whether to surgically treat an unruptured cerebral aneurysm, one must weigh the natural history of the condition against the risks of operative intervention. The annual risk of rupture of an unruptured cerebral aneurysm has been estimated by several investigations to range from 0.1 to 8% or higher, leading to much controversy regarding the appropriate management of these lesions. The publication of retrospective results from the International Study of Unruptured Intracranial Aneurysms (ISUIA), claiming that the risk of aSAH from aneurysms less than 10mm was drastically lower than previously accepted values (by a factor of [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] , began a debate favoring observation for the vast majority of small unruptured cerebral aneurysms (1) . To this end, we review critical investigations in this area, including the prospective ISUIA (94), the study by Juvela et al. with 18-year follow-up (37) , and the comprehensive meta-analysis by Rinkel and colleagues (69) .
ISUIA is an ongoing international collaboration of major neurosurgical centers with the goal of further delineating the natural history of unruptured intracranial aneurysms as well as interventional outcomes. Thus far, two landmark papers have been published, having a major impact on the evaluation of this condition. The first study (1) , published in the New England Journal of Medicine, contained a retrospective component designed to assess the natural history of unruptured intracranial aneurysms. In this analysis the authors reviewed 1449 patients with 1937 aneurysms. These patients were divided into two groups: 727 who had no history of aneurysmal SAH (Group 1), and 722 who had a history of aneurysmal SAH from a different lesion (Group 2). The mean follow-up duration was 8.3 years. For Group 1, the rate of SAH for aneurysms smaller than 10 mm was 0.05% per year, whereas for aneurysms larger than 10 mm it was approximately 1% per year. For Group 2, the SAH rate was 0.5% for aneurysms smaller than 10 mm and approximately 1% per year for aneurysms larger than 10 mm. These numbers were drastically lower than in the previous estimates. Evaluations of predictors of rupture found that increasing size and location (posterior circulation and PcomA) were significantly associated with rupture for Group 1, whereas location (basilar tip) and increasing age were predictive of rupture for Group 2. Although the large number of aneurysms and the multi-center nature of this study certainly make it an important contribution to the literature, it has a number of serious design flaws. The cohort of patients that made up the retrospective evaluation of the natural history of unruptured intracranial aneurysms was subjected to a very significant selection bias. All patients had already been evaluated for surgery and selected for observation by the participating neurosurgeon. Clearly this is a very different population from that of all patients with unruptured aneurysms. Since these patients had already been selected for conservative management of their lesions, it is likely that they harbored extremely low-risk aneurysms due to location (cavernous carotid aneurysms were identified in Groups 1 and 2 at rates of 16.9 and 9.5%, respectively) or small size (in Groups 1 and 2, 2-to 5-mm aneurysms were identified in 32.7 and 61.2% of patients, respectively). In addition, it is likely that the patients were medically ill, with increased deaths due to other causes removing them from the pool of possible patients with aneurysmal SAH. Moreover, patients whose lesions were originally selected for conservative management by their surgeons may have later crossed over to surgical treatment because of changes in symptoms or aneurysm size. This crossover would remove patients who were imminently at risk for SAH, possibly lowering the observed rupture rate.
The second study (94), published in Lancet, contains a prospective evaluation of the natural history of 2686 unruptured intracranial aneurysms in 1692 patients. In this analysis there were 1077 patients in Group 1 (those with no history of aneurysmal SAH), and 615 patients in Group 2 (those with a history of SAH). The mean follow-up duration was 4.1 years. Calculating the total risk of rupture for patients in both Groups 1 and 2, excluding those with aneurysms in the cavernous ICA, demonstrates that for aneurysms 7 to 12, 13 to 24, and greater than 25 mm in diameter the yearly rupture rates are 1.2, 3.1, and 8.6%, respectively. Unfortunately, the results for aneurysms smaller than 7 mm were presented in a stratified manner and therefore cannot be effectively combined. For patients in Group 2, aneurysms smaller than 7 mm, excluding those in the cavernous ICA, demonstrated a rupture rate of 0.4% per year, whereas for patients in Group 1, lesions smaller than 7 mm, excluding cavernous ICA aneurysms, demonstrated a 0.15% yearly rupture rate. It is important to note that, as observed in the retrospective study, the prospective ISUIA contained selection bias in the population studied. For instance, of the 1692 patients, 534 were switched to a therapeutic intervention (410 surgical, 124 endovascular) and were removed from follow-up. It is not unreasonable to conclude that in at least some significant portion of these crossover patients the management strategy was changed because of either an increase in aneurysm size or the development of new symptoms, both of which have been implicated in large increases in rupture rate.
Therefore, the population studied was not only created with an obvious selection bias, but also underwent a second selection process, by which aneurysms that may have been likely to rupture were removed from the cohort, despite the original intent to treat conservatively. Also of note, 193 patients (11%) died of causes other than aneurysmal SAH; these patients were removed from the analysis. This is a reasonable statistical technique, but it is troubling that 52 of these patients died of intracranial hemorrhage. It is unclear whether there was adequate evaluation to ensure that these intracranial hemorrhages were not due to aneurysms. In short, although the prospective ISUIA data is a useful guideline, some caution is indicated when extrapolating to the population at large.
Rinkel, et al., (69) published an invaluable analysis of the natural history of unruptured intracranial aneurysms in which they performed a thorough review of the literature published between 1955 and 1996. To estimate the prevalence of unruptured aneurysms, data were summed from 23 studies (eight autopsy, 15 angiography) to evaluate 56, 304 patients. The overall prevalence of these lesions in adults with no known specific risk factors (autosomal-dominant polycystic kidney disease, family history, atherosclerosis) was 2.3%. The method of aneurysm detection strongly influenced the estimate of prevalence; retrospective autopsy, prospective autopsy, retrospective angiographic, and prospective angiographic studies demonstrated rates of 0.4, 3.6, 3.7, and 6%, respectively. For analysis of the bleeding rate of unruptured intracranial aneurysms, the authors identified nine studies in which a total of 3907 patients were evaluated. The overall risk of rupture was 1.9% per year (0.7% for unruptured aneurysms <10 mm and 4% for intact lesions > 10 mm). It is important to realize that with any meta-analysis the final conclusions are only as good as the quality of the studies that are pooled to generate the data. That being said, the sheer number of patients analyzed and the detailed analysis performed by the authors make this study an important investigation into the natural history of unruptured intracranial aneurysms. Additionally, the results reported by Rinkel and colleagues are strengthened by the fact that their estimates of the prevalence of and incidence of bleeding in unruptured intracranial aneurysms corroborate very closely with the known incidence of aneurysmal SAH.
Juvela and colleagues (37) provide a comprehensive observational cohort study that lacks the inherent bias of surgical selection found in ISUIA, as they examined all patients with unruptured intracranial aneurysms seen at their institution over a given time period. This study was achievable because it was their department policy to manage all unruptured aneurysms conservatively prior to 1979. In addition, Finland's socio-medical structure allowed 100% follow-up to record outcome over a longer period of time (mean 18.1 years) than has been achieved in any other study. A total of 142 patients with 181 unruptured intracranial aneurysms were studied. The cumulative rate of aneurysmal SAH was 10.5% at 10 years, 23% at 20 years, and 30.3% at 30 years after the diagnoses were made. Aneurysm size and patient age (inversely) were significant predictors of aneurysmal SAH, as was active cigarette smoking (p < 0.05 for each). Major flaws in this study are the small total number of patients, the homogeneity of the study population (it is debatable whether the Finnish population's natural history can be extrapolated to other populations), and the overwhelming proportion (92%) of patients with previous aneurysmal SAH (it is unclear whether the natural history of incidental aneurysms is the same as that of secondarily discovered lesions after aneurysmal SAH of another etiology). Despite these major flaws, the lack of a surgical selection bias and the outstanding long-term follow-up ensure this study's equal footing with the ISUIA as far as providing imperfect but valuable data regarding the estimate of bleeding rates for unruptured intracranial aneurysms.
When interpreting the current literature regarding the natural history of unruptured cerebral aneurysms, there are several factors to be considered. For example, studies tend to break down aneurysms into size categories (ex. > or < 10mm). It is highly unlikely that such a cutoff will result in substantially different rupture rates. Rather, it must be understood that these arbitrary boundaries were set up by the investigators simply for ease of data collection, presentation, and comparison. In actuality, the risk of bleeding for unruptured intracranial aneurysms most likely reflects a non-linear continuum of exponentially increasing risk with greater aneurysm size. Additionally, it is important to realize that aneurysms may not be static, but have been demonstrated to undergo growth in a number of studies (8, (37) (38) (39) 82) . For instance, Juvela, et al. (37) (38) (39) found that in 31 of 87 (36%) patients the size of conservatively managed aneurysms grew at least 3 mm over a mean follow-up period of 18.9 years. The relative effect of aneurysm growth on our ability to estimate hemorrhage risk is unknown, but it would be illogical to assume that an 8-mm aneurysm will always stay 8 mm and never become an 11-mm aneurysm, and thereby acquire an increased rupture risk.
Second, any estimation of rupture risk must take into account the aneurysm location. For instance, the results of the ISUIA demonstrate that aneurysms of the PcomA and posterior circulation display a much higher risk of rupture (~2-7 times higher) than those of the middle cerebral artery and ICA. A survey of the literature indicates that posterior circulation, PcomA, and anterior communicating artery aneurysms carry the highest risk of SAH, whereas aneurysms of the cavernous ICA carry an extremely low rupture risk (1, 4, 8, 94 ).
Last, it has been our experience that there is a very real phenomenon of excessive psychological stress in patients harboring an unruptured intracranial aneurysm. Even when patients fall into a subgroup of minimal or unknown treatment benefit and are appropriately counseled, they often insist on treatment. Although rigorous studies of this
issue have yet to be performed, it appears that the psychological stress associated with harboring an unruptured intracranial aneurysm is great enough to cause a patient to forgo the conservative management recommended in the literature for the perceived peace of mind in knowing that a treatment has been exercised (62) . Our universal policy is to recommend management based on our experience with thousands of aneurysm patients and according to our best interpretation of the literature. However, there is a subset of patients who insist on an intervention regardless of our recommendation. These patients may be borderline candidates to begin with, and such strong feelings on the patients' part indicating quality of life issues may tilt the risk/benefit analysis toward performing an intervention.
Despite conflicting data in the current literature, we have the following recommendations. The natural history of a given unruptured intracranial aneurysm should be individually assessed for each case, since there are a number of factors that alter predicted rupture rates. For instance, family history, smoking, excessive alcohol consumption, female sex, previous aneurysmal SAH, presence of symptoms attributable to the lesion, aneurysm location, and lesion size have all been demonstrated to predict a worse natural history (12, 20, 38-40, 44, 54, 59, 73, 74, 77) . Therefore, all of these factors must be taken into account when evaluating an unruptured intracranial aneurysm.
In addition, any risk/benefit analysis of proceeding with intervention must take into account the patient's life expectancy and medical comorbidities. Despite these important concerns, it is helpful to have a general, nonspecific algorithm for predicting rupture risk that may then be adjusted appropriately depending on the aforementioned risk factors.
Of the two ISUIAs, the prospective portion most likely provides the best estimate of the natural history of unruptured intracranial aneurysms. However, the reported selection bias and questionable study design make it highly likely that this paper underestimates the risk of bleeding in some groups of unruptured intracranial aneurysms. The paper by Juvela, et al., is the best designed and executed investigation, but due to its observational nature, it is also subject to significant selection bias, because it has been suggested that the Finnish population has a higher incidence of aneurysmal SAH than the international 
SURGICAL TREATMENT OF UNRUPTURED ANEURYSMS

Indications for Surgery
Microsurgical clipping excludes an aneurysm from the parent circulation and offers 
Morbidity and Mortality of Surgery
In addition to understanding the natural history of unruptured cerebral aneurysms, implementing a therapeutic paradigm with highly experienced cerebrovascular surgeons designed to offer low-risk treatments is essential to the management of this patient population. While the morbidity and mortality of aneurysm surgery clearly depends on the particular neurosurgeon and medical center being evaluated, several studies have attempted to formulate currently acceptable values. Unfortunately, no consensus has been reached. As Benderson et al. pointed out in their 2000 review, these values range from 0-7% for death and from 4-15% for complications (7) . By comparison, endovascular coiling has been shown to carry complication rates of 0.9-30.0% (6, 15, 17, 21, 25, 27, 33-36, 45, 47, 53, 57, 63, 65, 72, 90, 94) With the advent of improved technology and operative techniques, the risks associated with unruptured aneurysm surgery have trended down over time (76) . In 1983, Wirth et al. retrospectively reviewed the outcomes following unruptured aneurysm treatment at 12 medical centers (95) . Excluding those lesions associated with an intracerebral hematoma, arteriovenous malformations, or tumor, the authors compiled 107 incidentally discovered aneurysms and reported 7% permanent morbidity rate and 8% transient morbidity rate following surgery. Further analysis revealed risk of operative morbidity was associated with lesion size and location, with lesions <5mm, 2%; 6-15mm, 7%; 16-24mm, 14%; posterior communicating artery (PcomA), 5%; middle cerebral artery (MCA), 8%; internal carotid artery (ICA), 12%; and anterior communicating artery (AcomA), 16%.
Poor outcome occurred more often in patients presenting with ischemic symptoms (11%), as compared to those presenting with headache (6%).
In 1990, Rice et al. reported their series of microsurgery for 179 posterior circulation unruptured aneurysms over a 17-year period (68) . The majority of these lesions were asymptomatic (89%), located at the basilar apex (84%), smaller than 12mm (72%), and part of a multiple constellation syndrome (68%). Giant aneurysms were excluded from the study. The authors report encouraging postoperative morbidity and mortality rates of 3.6 and 0.5%, respectively.
In 1991, Hadeishi and colleagues cited that 18 of 72 (25%) of their patients undergoing unruptured aneurysm surgery experienced neurological deficits (28) . The authors note, however, the transient nature of these deficits, as the overwhelming majority of patients (17 of 18), had resolution of their symptoms within two weeks, with only one patient demonstrating persistent dysarthria. In another study by Matsumoto and associates, initial outcomes after treatment of 84 unruptured cerebral aneurysms revealed a relatively high morbidity rate of 13.1% (48) . Fortunately, over half of these deficits resolved upon follow-up, dropping the final morbidity rate to 5.9%. Not unexpectedly, the occurrence of postoperative neurological deficits was correlated with the patient's medical comorbidities, increasing aneurysm size, posterior circulation aneurysms, and the presence of multiple lesions.
A 1994 paper from Columbia University documented outcomes after 202 consecutive surgeries for microsurgical clipping of unruptured cerebral aneurysms (78) . Overall, minor complications, major complications, and death occurred in 5%, 7%, and 3.5% of patients, respectively. Further cohort analysis, however, showed 100% of patients with lesions smaller than 10mm experienced excellent or good outcomes. In contrast, patients with lesions 11-25mm and >25mm in diameter had similar outcomes in 95% and 79% of cases, respectively, further supporting the notion that aneurysm size is an essential predictor of operative related morbidity and mortality. Of note, 56% of lesions were symptomatic, and the majority (50%) were located on the ICA. In patients with incidental aneurysms (17%), the mortality rate was 2.9%. During the follow-up period The authors identified 10 type I studies (retrospective studies from a single institution) and 4 type II studies (multicenter or community-based studies). In general, type I studies reported excellent surgical outcome, with mean combined mortality and morbidity of 7.8%, as opposed to a mean combined mortality and morbidity of 20.3% in type II studies. This translated into a relative risk of 2.6 for patients enrolled in type II studies compared with those in type I studies. This paper emphasizes the presence of publication bias in neurosurgery literature, as studies with an excellent surgical outcome are more likely to be published than those with an average outcome. As a result, conclusions based on reviews or meta-analyses may be misleading. The authors suggest generating a community-based prospective registration for all such patients, thereby providing a sampling frame free from publication bias.
The morbidity and mortality of surgery for unruptured cerebral aneurysms was one of the main outcomes assessed in the ISUIA studies (1, 94) . The initial cohort studied consisted of 1172 patients, of which 211 had a prior history of SAH from another lesion (1). Many of these unruptured aneurysms were symptomatic, with 34% having headaches, 14% with cranial nerve deficits, 11% with cerebrovascular ischemic events, 6% with lesion-induced mass effect, and 5% with epilepsy. The authors found age dependent outcomes, as the morbidity and mortality at one-year follow-up for patients younger than 45 to be 6.5%; for those [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] 14 .4%, and for those older than 64, 32% (p<0.001). Surprisingly, 3.1% of the treated patients without prior aSAH died from operative-related complications compared with only 0.9% of those with a history of aSAH. Close inspection, however, reveals that the latter group was on average younger (47 vs. 53-years-old) and harbored smaller aneurysms (27 vs Findings included 1.8% and 12.0% mortality and morbidity at 30 days, and 2.7% and 10.1% mortality and morbidity at 1 year. In this cohort, asymptomatic patients younger than 50 years of age with unruptured aneurysms less than 24mm in diameter located in the anterior circulation had the lowest rates of surgical risk, quoted at 5-6% at 1 year.
When interpreting these results against those of other studies, it is important to recognize that both ISUIA studies included major cognitive impairment in their analysis, which was not considered in the vast majority of prior papers.
In 2005, Moroi released their results after treating 549 unruptured aneurysms at the Research Institute for Brain and Blood Vessels (51) . Their reported success is remarkable, with 0.3% mortality and 2.2% morbidity overall. More specifically, for aneurysms less than 10mm their mortality and morbidity was only 0.0 and 0.6%, and for aneurysms greater than 10mm these rates were 1.2 and 6.1%. The authors also divided their outcome by lesion location, with essentially 0% risk for all ACA and MCA aneurysms. ICA aneurysms carried anywhere from a 0% mortality and 1.0% morbidity rate for those less than 5mm, to 12.5% mortality and 25.0% morbidity rate for those greater than 20mm. Vertebrobasilar aneurysms were associated with a 0% mortality and morbidity rate for those lesions less than 5mm and 11.1% morbidity rate for those greater than 5mm.
A meta-analysis of outcomes following unruptured aneurysm surgery was published by Raaymakers and colleagues in 1998, and represents the most comprehensive review to date (64) . The authors of this paper reported 2.6% mortality and 10.9% morbidity rates in 2460 patients, substantially higher than those quoted in a prior meta-analysis by King et al (42) . In general, complications tended to be serious, with half of affected individuals becoming dependent on others for their activities of daily living. Mortality rates varied substantially, with 62% of studies reporting no deaths, while other studies demonstrated death rates as high as 29%. As a general trend, mortality rates were lower in more recent studies and those with a greater proportion of anterior circulation lesions.
Giant aneurysm surgery carried a poor prognosis regardless of publication year.
Specifically, the authors found the following mortality and morbidity rates: giant posterior circulation aneurysms (9.6 and 37.9%); giant anterior circulation aneurysms aneurysms (41) . Results revealed that correlation between scores were poor (0.15 when the GOS was compared with the MMSE and 0.27 when compared with the SF-36) and many patients given the highest GOS or Rankin scores showed significant cognitive deficits. These findings emphasize the importance of incorporating cognitive outcome measures when accurately estimating the morbidity and mortality of aneurysm surgery.
Regionalization of Aneurysm Management
Several studies have investigated the role of regionalization in aneurysm management. In 1996, Solomon et al. found an inverse relationship between the volume of craniotomies for aneurysm clipping performed and in-hospital mortality rates (79) . The authors reviewed 47,408 patients reported in the New York State database during an eight-year period. The data demonstrated a 43% decrease in mortality rate in hospitals performing at least 30 craniotomies for aneurysm clipping per year versus lower volume hospitals (4.6% versus 8.1% mortality, respectively). Divided by case volume, there was 12% mortality in hospitals performing <6 craniotomies/year, 11% mortality in hospitals performing 6-10 craniotomies/year, 7% mortality in hospitals performing [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] craniotomies/year, 5% mortality in hospitals performing 21-30 craniotomies/year, 6% mortality in hospitals performing 31-100 craniotomies/year, and only 3% mortality in hospitals performing >100 craniotomies/year. Overall, there appears to be an inflection point at 30 aneurysm operations per year where the morbidity and mortality rates change substantially between hospitals. In addition, one must consider that complex and technically challenging aneurysms are usually referred to tertiary, high-volume medical centers, while straightforward cases are treated at low-volume hospitals.
Although the majority of high volume hospitals are academic medical centers, concern exists regarding the impact of resident education on outcome during technically difficult cases. In 1997, however, Taylor showed that surgery-related mortality was significantly lower (16.3%) in teaching hospitals than in non-teaching ones (23.1%) with equal operative volume (83) . In 2001, Johnston and colleagues utilized the California state database to review the outcomes following surgery for unruptured cerebral aneurysms in 1321 patients (36) . The data revealed that adverse events, including death or discharge to a nursing home or rehabilitation hospitals, occurred significantly more often at lowvolume hospitals. More specifically, in-hospital death was 2.5 times more likely at non- 
Rates of Recurrence
Microsurgical aneurysm clipping has been demonstrated to provide definitive long-term treatment of cerebral aneurysms. Spetzler and colleagues reviewed 160 surgically managed aneurysm that underwent late angiographic follow-up (mean 4.4 years postoperatively) and found only 1.5% of initially obliterated lesions exhibited recurrence (19) . In aneurysms with known residua, 25% enlarged on follow-up imaging. Eight new lesions developed in six patients. This translates into a 0.52% annual regrowth rate for completely clipped aneurysms and a 1.8% annual rate of de novo aneurysm formation.
Not unexpectedly, patients with multiple lesions were found to be at higher risk for de novo aneurysms. Tsutsumi In contrast, the recurrence rate of coiled aneurysms has been reported to be much higher. advanced GDC technology. Of note, recanalization was related to the size of the dome and neck of the aneurysm. In small aneurysms (4-10mm) with small necks ( 4mm) the overall recanalization rate was only 5.1%. In contrast, for small aneurysms with wide necks (4mm) the overall recanalization rate was 20%. Moreover, among large aneurysms (11-25mm) and giant aneurysms (25mm) the overall recanalization rate was 35% and 59.1%, respectively. These data strongly suggest that while clinical and postembolization outcomes in patients treated with the GDC system have improved over time, larger lesions with wider necks continue to carry a high risk for recanalization.
CONCLUSIONS AND RECOMMENDATIONS
In 2000, the Stroke Council of the American Heart Association issued a scientific statement with the following recommendations for the management of unruptured intracranial aneurysms (7): "In consideration of the apparent low risk of hemorrhage from incidental small (<10 mm) aneurysms in patients without previous SAH, treatment rather than observation cannot be generally advocated." This statement is now clearly antiquated, and it is time for a new consensus committee to issue updated recommendations. The most conclusive data regarding the natural history of unruptured intracranial aneurysms is from ISUIA (1, 94) and Juvela's Helsinki experience (37).
Vinuela's experience with aneurysm regrowth after coil embolization gives important insight for comparison to the relative permanence of surgical clipping (39).
Raaymaker's meta-analysis of the literature on surgical morbidity for clipping of unruptured aneurysms (64) compares almost exactly with our own published data (56) and ongoing experience. These published data sets and our own experience, provide an invaluable although imperfect framework for the following structured guidelines: 1) With rare exceptions, all symptomatic unruptured aneurysms should be treated.
Extensive medical comorbidity, advanced age, and anatomic configuration of the aneurysm may contraindicate intervention when treatment risks approach 25%.
2) Small, incidental aneurysms less than 5mm should be managed conservatively in virtually all cases. An important exception to this rule involves those young patients with severe psychological disturbances secondary to harboring an unruptured aneurysm. In such patients, particularly those psychologically crippled by their condition, definitive treatment can be justified and is often pursued.
3) Aneurysms greater than 5mm in patients less than 60 years of age should be offered treatment unless there is a significant contraindication. Although 7mm was the cut-off in the ISUIA data, there are limitations to using such an exact measurement, particularly since this study was limited by selection bias. Certainly aneurysms less than 7mm in diameter are known to infrequently rupture. The accuracy of measurement, even with angiographic data, is at least  2mm. Therefore, if 7mm is used as a cutoff, some aneurysms will not be treated that should be treated. Rather, we suggest using a standard error of measurement below this cut-off, so that the 99% of patients at risk for rupture are offered treatment. When managing older patients (>60 years of age) the decision to treat becomes less clear. In these situations, lesion location plays a critical role, as AcomA, PcomA, and basilar apex aneurysms carry higher rupture risk than aneurysms in other locations. Thus, we strongly advocate treatment of such lesions, even in older healthy individuals, since there is low associated treatment morbidity. 4) Large, incidental aneurysms greater than 10mm should treated in all healthy patients less than 70 years of age. The indications are less compelling in older individuals. 5) Microsurgical clipping rather than endovascular coiling should be the first choice in low-risk cases (young patients with small, anterior circulation aneurysms). In these cases, the risk of open microsurgery and endovascular surgery is about the same in terms of stroke and death, although endovascular coiling is definitely less invasive. On the other hand, surgical clipping provides a repair that is at least an order of magnitude more durable than coiling. In cases where the invasion of clipping and the 6 weeks of recuperation do not pose an undo risk or hardship, clipping is a better option.
Very large and giant aneurysms, and aneurysms with high neck to dome ratios, will generally benefit more from surgical approaches than from endovascular treatment. In the most complex aneurysms, combined approaches such as arterial bypass techniques followed by proximal endovascular occlusion, have proved invaluable. Endovascular coiling represents a reasonable alternative that should be instituted whenever open surgical intervention carries high risk such as with elderly or medically ill patients and in anatomically unfavorable situations (ex. posterior projecting basilar apex aneurysm). The improvement in stent and coil technology offers an excellent alternative in this group of poor surgical candidates, even in those aneurysms with wide necks and unfavorable neck/dome ratios.
